Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BSQR
2551
DELISTED
BSQUARE Corporation
BSQR
| $1.12M | ﹤0.01% |
935,679
-1,300
| -0.1% | -$1.62K |
|
2552
Fuel Tech
FTEK
$43.9M
| $1.12M | ﹤0.01% |
1,133,251
+32,113
| +3% | +$34.3K |
|
2553
Iovance Biotherapeutics
IOVA
$1.82B
| $1.12M | ﹤0.01% |
+61,400
| New | +$1.36M |
|
2554
Cartesian Therapeutics
RNAC
$229M
| $1.11M | ﹤0.01% |
21,146
+5,429
| +35% | +$289K |
|
|
FRTX
2555
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $1.11M | ﹤0.01% |
5,892
+947
| +19% | +$217K |
|
2556
Limoneira
LMNR
$235M
| $1.1M | ﹤0.01% |
+60,200
| New | +$1.15M |
|
|
CYRN
2557
DELISTED
CYREN Ltd.
CYRN
| $1.1M | ﹤0.01% |
32,565
+127
| +0.4% | +$4.13K |
|
|
SGMA
2558
DELISTED
Sigmatron International
SGMA
| $1.09M | ﹤0.01% |
267,390
+23,861
| +10% | +$91.5K |
|
|
PENG
2559
Penguin Solutions Inc
PENG
$2.7B
| $1.08M | ﹤0.01% |
85,200
-143,000
| -63% | -$2.07M |
|
|
NAAS
2560
NaaS Technology Inc
NAAS
$55.2M
| $1.08M | ﹤0.01% |
16
+4
| +33% | +$271K |
|
2561
SIGA Technologies
SIGA
$235M
| $1.08M | ﹤0.01% |
211,600
+124,300
| +142% | +$670K |
|
|
CIVI
2562
DELISTED
Civitas Resources
CIVI
| $1.08M | ﹤0.01% |
+48,200
| New | +$1.07M |
|
2563
Forum Energy Technologies
FET
$708M
| $1.08M | ﹤0.01% |
34,817
+22,727
| +188% | +$934K |
|
2564
Navios Maritime Partners
NMM
$2.3B
| $1.08M | ﹤0.01% |
60,686
-131,863
| -68% | -$2.2M |
|
2565
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
| $1.08M | ﹤0.01% |
7,200
-1,200
| -14% | -$176K |
|
2566
Mitek Systems
MITK
$754M
| $1.07M | ﹤0.01% |
111,289
-124,287
| -53% | -$1.24M |
|
2567
Microbot Medical
MBOT
$116M
| $1.07M | ﹤0.01% |
201,549
-5,338
| -3% | -$31.2K |
|
2568
Immersion
IMMR
$251M
| $1.06M | ﹤0.01% |
139,013
-16,700
| -11% | -$132K |
|
|
TGP
2569
DELISTED
Teekay LNG Partners L.P.
TGP
| $1.06M | ﹤0.01% |
77,732
-35,068
| -31% | -$523K |
|
|
CORV
2570
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $1.06M | ﹤0.01% |
528,975
-38,673
| -7% | -$78.3K |
|
2571
Lands' End
LE
$370M
| $1.06M | ﹤0.01% |
93,170
-37,200
| -29% | -$393K |
|
|
RAD
2572
DELISTED
Rite Aid Corporation
RAD
| $1.06M | ﹤0.01% |
152,100
+29,000
| +24% | +$208K |
|
2573
Eagle Bancorp Montana
EBMT
$187M
| $1.05M | ﹤0.01% |
60,032
+11,472
| +24% | +$192K |
|
|
MYND
2574
Mynd.ai
MYND
$18M
| $1.05M | ﹤0.01% |
16,364
+2,310
| +16% | +$148K |
|
2575
Beasley Broadcasting Group
BBGI
$37.8M
| $1.05M | ﹤0.01% |
16,910
+1,135
| +7% | +$71.6K |
|
Similar funds
Renaissance Technologies's Q3 2019 Portfolio in Review
As of Q3 2019, Renaissance Technologies held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Renaissance Technologies's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Renaissance Technologies added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Renaissance Technologies's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Renaissance Technologies fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Renaissance Technologies's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Renaissance Technologies opened 406 new positions and closed 522 in Q3 2019.
- Renaissance Technologies's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.